Brazilian Dialysis Survey 2021

ABSTRACT Introduction: The Brazilian Dialysis Survey (BDS) is an important source of national data about people on chronic dialysis that contributes to the formulation of health policies regarding kidney failure. Objective: To report the 2021 epidemiological data from the BDS of the Brazilian Society of Nephrology (BSN). Methods: A survey was carried out in Brazilian chronic dialysis centers using an online questionnaire covering clinical and epidemiological aspects of patients in chronic dialysis, data on dialysis therapy, characteristics of dialysis centers, and the impact of the COVID-19 pandemic of 2021. Results: Thirty percent (n = 252) of the centers answered the questionnaire. In July 2021, the estimated total number of patients on dialysis was 148,363. The estimated prevalence and incidence rates of patients per million population (pmp) were 696 and 224, respectively. Of the prevalent patients, 94.2% were on hemodialysis (HD) (1.8% of these on hemodiafiltration), and 5.8% on peritoneal dialysis (PD); 21% were on the transplant waiting list. The incidence rate of confirmed COVID-19 between January and July 2021 was 1,236/10,000 dialysis patients, and the case-fatality rate reached 25.5%. Up to July 2021, 88.6% of patients had received at least one dose of the anti-SARS-CoV-2 vaccine. The estimated overall and COVID-19 crude annual mortality rates were 22.3% and 5.3%, respectively. Conclusion: The absolute number and the prevalence rate of patients on chronic dialysis continue to increase. Most dialysis patients were vaccinated against COVID-19 during the year. The COVID-19 pandemic was associated to the overall mortality rate.

Saved in:
Bibliographic Details
Main Authors: Nerbass,Fabiana B, Lima,Helbert do Nascimento, Thomé,Fernando Saldanha, Vieira Neto,Osvaldo Merege, Sesso,Ricardo, Lugon,Jocemir Ronaldo
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Nefrologia 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005056401
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0101-28002022005056401
record_format ojs
spelling oai:scielo:S0101-280020220050564012022-11-01Brazilian Dialysis Survey 2021Nerbass,Fabiana BLima,Helbert do NascimentoThomé,Fernando SaldanhaVieira Neto,Osvaldo MeregeSesso,RicardoLugon,Jocemir Ronaldo Renal Dialysis Peritoneal Dialysis Epidemiology COVID-19 ABSTRACT Introduction: The Brazilian Dialysis Survey (BDS) is an important source of national data about people on chronic dialysis that contributes to the formulation of health policies regarding kidney failure. Objective: To report the 2021 epidemiological data from the BDS of the Brazilian Society of Nephrology (BSN). Methods: A survey was carried out in Brazilian chronic dialysis centers using an online questionnaire covering clinical and epidemiological aspects of patients in chronic dialysis, data on dialysis therapy, characteristics of dialysis centers, and the impact of the COVID-19 pandemic of 2021. Results: Thirty percent (n = 252) of the centers answered the questionnaire. In July 2021, the estimated total number of patients on dialysis was 148,363. The estimated prevalence and incidence rates of patients per million population (pmp) were 696 and 224, respectively. Of the prevalent patients, 94.2% were on hemodialysis (HD) (1.8% of these on hemodiafiltration), and 5.8% on peritoneal dialysis (PD); 21% were on the transplant waiting list. The incidence rate of confirmed COVID-19 between January and July 2021 was 1,236/10,000 dialysis patients, and the case-fatality rate reached 25.5%. Up to July 2021, 88.6% of patients had received at least one dose of the anti-SARS-CoV-2 vaccine. The estimated overall and COVID-19 crude annual mortality rates were 22.3% and 5.3%, respectively. Conclusion: The absolute number and the prevalence rate of patients on chronic dialysis continue to increase. Most dialysis patients were vaccinated against COVID-19 during the year. The COVID-19 pandemic was associated to the overall mortality rate.info:eu-repo/semantics/openAccessSociedade Brasileira de NefrologiaBrazilian Journal of Nephrology n.ahead 20222022-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005056401en10.1590/2175-8239-jbn-2022-0083en
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Nerbass,Fabiana B
Lima,Helbert do Nascimento
Thomé,Fernando Saldanha
Vieira Neto,Osvaldo Merege
Sesso,Ricardo
Lugon,Jocemir Ronaldo
spellingShingle Nerbass,Fabiana B
Lima,Helbert do Nascimento
Thomé,Fernando Saldanha
Vieira Neto,Osvaldo Merege
Sesso,Ricardo
Lugon,Jocemir Ronaldo
Brazilian Dialysis Survey 2021
author_facet Nerbass,Fabiana B
Lima,Helbert do Nascimento
Thomé,Fernando Saldanha
Vieira Neto,Osvaldo Merege
Sesso,Ricardo
Lugon,Jocemir Ronaldo
author_sort Nerbass,Fabiana B
title Brazilian Dialysis Survey 2021
title_short Brazilian Dialysis Survey 2021
title_full Brazilian Dialysis Survey 2021
title_fullStr Brazilian Dialysis Survey 2021
title_full_unstemmed Brazilian Dialysis Survey 2021
title_sort brazilian dialysis survey 2021
description ABSTRACT Introduction: The Brazilian Dialysis Survey (BDS) is an important source of national data about people on chronic dialysis that contributes to the formulation of health policies regarding kidney failure. Objective: To report the 2021 epidemiological data from the BDS of the Brazilian Society of Nephrology (BSN). Methods: A survey was carried out in Brazilian chronic dialysis centers using an online questionnaire covering clinical and epidemiological aspects of patients in chronic dialysis, data on dialysis therapy, characteristics of dialysis centers, and the impact of the COVID-19 pandemic of 2021. Results: Thirty percent (n = 252) of the centers answered the questionnaire. In July 2021, the estimated total number of patients on dialysis was 148,363. The estimated prevalence and incidence rates of patients per million population (pmp) were 696 and 224, respectively. Of the prevalent patients, 94.2% were on hemodialysis (HD) (1.8% of these on hemodiafiltration), and 5.8% on peritoneal dialysis (PD); 21% were on the transplant waiting list. The incidence rate of confirmed COVID-19 between January and July 2021 was 1,236/10,000 dialysis patients, and the case-fatality rate reached 25.5%. Up to July 2021, 88.6% of patients had received at least one dose of the anti-SARS-CoV-2 vaccine. The estimated overall and COVID-19 crude annual mortality rates were 22.3% and 5.3%, respectively. Conclusion: The absolute number and the prevalence rate of patients on chronic dialysis continue to increase. Most dialysis patients were vaccinated against COVID-19 during the year. The COVID-19 pandemic was associated to the overall mortality rate.
publisher Sociedade Brasileira de Nefrologia
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005056401
work_keys_str_mv AT nerbassfabianab braziliandialysissurvey2021
AT limahelbertdonascimento braziliandialysissurvey2021
AT thomefernandosaldanha braziliandialysissurvey2021
AT vieiranetoosvaldomerege braziliandialysissurvey2021
AT sessoricardo braziliandialysissurvey2021
AT lugonjocemirronaldo braziliandialysissurvey2021
_version_ 1756392769524334592